Alastair Hick

Alastair Hick is a seasoned professional in commercialization and innovation, currently serving as Director at BioCurate Pty Ltd and Uniseed, and Chair at both Phrenix Therapeutics and Myostellar. With extensive experience at Monash University since February 2007, Alastair holds the position of Chief Commercialisation Officer, overseeing all commercialization activities and leading the Monash Innovation team. Alastair is also a member of the National Health and Medical Research Council's Health Research Impact Committee. Previous roles include directorships at Jupiter Ionics, PIOtx, and Amaero International Limited, as well as leadership positions with Knowledge Commercialisation Australasia Ltd. Alastair's academic credentials include an MBA from Cambridge Judge Business School, a PhD from The Open University, and a BSc from the University of Southampton.